MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Nu-Seals 75 gastro-resistant tablets (Alliance Pharmaceuticals Ltd).

Stability Notes

Should be stored in tight, light resistant containers and protected from excessive moisture.

Provenance

This compatibility recommendation is derived from Clarityn Allergy 10mg tablets (Bayer Plc) and Loratadine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in airtight containers, protect from light. Store in tight or well-closed containers.

Provenance

This compatibility recommendation is derived from Piriton 4mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from generic co-codamol 8mg/500mg tablets.

Stability Notes

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Imodium IBS Relief 2mg capsules (McNeil Products Ltd).

Stability Notes

Orodispersible tablet, so unsuitable for inclusion in MCA.

Provenance

This compatibility recommendation is derived from Imodium Instant Melts 2mg orodispersible tablets (McNeil Products Ltd).

Stability Notes

Protect from light and moisture. Store in airtight containers.

Provenance

This compatibility recommendation is derived from generic cetirizine 10mg tablets.

Stability Notes

Protect from excessive moisture.

Provenance

This compatibility recommendation is derived from Fexofenadine 120mg tablets (Dr Reddy's Laboratories (UK) Ltd) and Telfast 120mg tablets (Sanofi).

Stability Notes

Protect from light. Protect from moisture.

Provenance

This compatibility recommendation is derived from Brufen 400mg tablets (Viatris UK Healthcare Ltd) and Ibuprofen 400mg tablets (Wockhardt UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.